A detailed history of Bluestein R H & CO LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Bluestein R H & CO LLC holds 329,514 shares of ABT stock, worth $44.5 Million. This represents 1.98% of its overall portfolio holdings.

Number of Shares
329,514
Previous 345,860 4.73%
Holding current value
$44.5 Million
Previous $37.6 Million 15.15%
% of portfolio
1.98%
Previous 2.31%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $1.58 Million - $1.83 Million
-16,346 Reduced 4.73%
329,514 $31.9 Million
Q2 2022

Aug 11, 2022

SELL
$102.07 - $123.37 $976,401 - $1.18 Million
-9,566 Reduced 2.69%
345,860 $37.6 Million
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $3.9 Million - $4.75 Million
-34,191 Reduced 8.78%
355,426 $42.1 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $1.81 Million - $2.21 Million
15,654 Added 4.19%
389,617 $54.8 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $483,322 - $534,695
4,143 Added 1.12%
373,963 $44.2 Million
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $1.79 Million - $2.11 Million
16,952 Added 4.8%
369,820 $42.9 Million
Q1 2021

May 12, 2021

BUY
$108.84 - $128.23 $218,441 - $257,357
2,007 Added 0.57%
352,868 $42.3 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $549,885 - $599,217
5,237 Added 1.52%
350,861 $38.4 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $5.21 Million - $6.32 Million
56,809 Added 19.67%
345,624 $37.6 Million
Q2 2020

Aug 12, 2020

SELL
$76.57 - $98.0 $621,978 - $796,054
-8,123 Reduced 2.74%
288,815 $26.4 Million
Q1 2020

May 12, 2020

SELL
$62.82 - $91.86 $1.22 Million - $1.78 Million
-19,409 Reduced 6.14%
296,938 $23.4 Million
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $2.49 Million - $2.77 Million
31,653 Added 11.12%
316,347 $27.5 Million
Q3 2019

Nov 13, 2019

BUY
$81.84 - $88.74 $2.19 Million - $2.38 Million
26,784 Added 10.39%
284,694 $23.8 Million
Q2 2019

Aug 12, 2019

BUY
$72.88 - $85.0 $1.93 Million - $2.25 Million
26,470 Added 11.44%
257,910 $21.7 Million
Q1 2019

May 10, 2019

BUY
$66.22 - $80.06 $5.03 Million - $6.09 Million
76,021 Added 48.91%
231,440 $18.5 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $10.2 Million - $11.5 Million
155,419 New
155,419 $11.2 Million
Q1 2018

May 10, 2018

SELL
$56.27 - $63.62 $321,864 - $363,906
-5,720 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$53.68 - $57.47 $307,049 - $328,728
5,720
5,720 $326,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $236B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bluestein R H & CO LLC Portfolio

Follow Bluestein R H & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluestein R H & CO LLC with notifications on news.